CIAM
IMCR icon

Caitong International Asset Management’s Immunocore IMCR Stock Holding History

Caitong International Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-42
Closed -$1.27K – 3211
2026
Q1 		$1.27K Sell
42
-441
-91% -$14.3K ﹤0.01% 1356
2025
Q4 		$16.8K Buy
483
+233
+93% +$8.22K ﹤0.01% 1032
2025
Q3 		$9.08K Sell
250
-1,045
-81% -$35.5K 0.01% 1045
2025
Q2 		$40.6K Buy
1,295
+1,268
+4,696% +$39.4K 0.03% 310
2025
Q1 		$801 Buy
+27
New +$810 ﹤0.01% 1638

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Caitong International Asset Management's IMCR Position: Q2 2026 in Review

Caitong International Asset Management sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 42 shares — an estimated $1.27K sold.

Caitong International Asset Management first reported a position in IMCR in Q1 2025 and held it in 5 quarters. The position peaked at $40.6K in Q2 2025. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Caitong International Asset Management reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 42 Immunocore shares in Q2 2026, an estimated $1.27K.
  • Caitong International Asset Management first reported a position in Immunocore in Q1 2025 and held it in 5 quarters.
  • Caitong International Asset Management's Immunocore position peaked at $40.6K in Q2 2025.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.